Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Rises after Shift in Company’s Board
Barron's
Wednesday, December 14, 2011 - 9:44am
tags:
Pfizer, Ian Read
5 Healthcare Merger Candidates To Consider
Seeking Alpha
Wednesday, December 14, 2011 - 9:43am
tags:
Pfizer, Watson, Becton Dickinson, Obagi Medical Products, PhotoMedex
Pfizer elects CEO Read as company chair
Fierce Pharma
Tuesday, December 13, 2011 - 11:58am
tags:
Pfizer, Ian Read, Pharma CEOs
Endocyte plunges on drug study results
Marketwatch
Tuesday, December 13, 2011 - 11:56am
tags:
Endocyte, EC145, ovarian cancer
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Bloomberg
Tuesday, December 13, 2011 - 11:48am
tags:
Adcetris, Seattle Genetics, Hodgkin's lymphoma
Avanir's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Tuesday, December 13, 2011 - 11:47am
tags:
Avanir, earnings
An Overview Of Antares' And Teva's Collaboration On Self-Injection Drugs
Seeking Alpha
Tuesday, December 13, 2011 - 11:46am
tags:
Teva Pharmaceuticals, Antares, self-injectibles
Anacor Pharma's skin drugs show promise in mid-stage trial
Reuters
Tuesday, December 13, 2011 - 11:45am
tags:
Anacor, eczema, AN2728
Sebelius Says Teva Can Reapply to End Morning-After Pill Limits for Girls
Bloomberg
Tuesday, December 13, 2011 - 11:11am
tags:
Teva Pharmaceuticals, morning-after pill, Plan B contraceptive
2 Reasons To Consider Investing In Pfizer Now
Seeking Alpha
Tuesday, December 13, 2011 - 11:10am
tags:
Pfizer
Abbott: This Market Leader Is A Buy
Seeking Alpha
Tuesday, December 13, 2011 - 11:08am
tags:
Abbott Laboratories
N.C. Novartis Site Is First Cell-Based Flu Vaccine Facility in the Country
Motley Fool
Tuesday, December 13, 2011 - 11:07am
tags:
North Carolina, Novartis, flu vaccines, drug manufacturing
YM Bio's Myelofibrosis Drug Is For Real
TheStreet.com
Tuesday, December 13, 2011 - 9:31am
tags:
YM BioSciences, myelofibrosis, CYT387
Jazz Pharmaceuticals shareholders OK Azur deal
Yahoo/AP
Tuesday, December 13, 2011 - 9:30am
tags:
M&A, Azur Pharma, Jazz Pharmaceuticals
J&J to release new Doxil batches
Fierce Pharma
Tuesday, December 13, 2011 - 9:27am
tags:
JNJ, Doxil, cancer, Boehringer Ingelheim
Disclosed: SIGA Technologies Receives $36M Payment From HHS
Seeking Alpha
Tuesday, December 13, 2011 - 9:24am
tags:
SIGA technologies, HHS, Abbott Laboratories, GSK, Novartis, PharmAthene
Ampio Pharmaceuticals: Straight Out Of Isolagen's Playbook
Seeking Alpha
Tuesday, December 13, 2011 - 9:23am
tags:
Isolagen, Ampio
S.E.C. Accuses Stiefel Labs and Its Ex-Chief of Fraud
NY Times, NY
Tuesday, December 13, 2011 - 8:10am
tags:
fraud, SEC, Stiefel Labs, GSK, Charles Stiefel
Merck to gain rights to Mochida diabetes drug
Reuters
Tuesday, December 13, 2011 - 8:09am
tags:
Merck, diabetes, Mochida
Pfizer Boosts Dividend, Expands Buyback
TheStreet.com
Tuesday, December 13, 2011 - 7:58am
tags:
dividend, stock buyback, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.